SLEdgehammer

Breaking the vicious autoimmunity cycle in autoimmune diseases

Over 5 million patients worldwide suffer from the chronic autoimmune disease Systemic Lupus Erythematosus, SLE. Today there is a lack of effective treatments for the disease.

SLEdgeHammer is developing a novel drug candidate for treating autoimmune diseases, such as SLE. By modulating two signaling pathways by one molecule, they aim to break the vicious autoimmunity cycle of the disease.

Team & KTH connection

SLEdgeHammer was founded by Johan Rockberg, Julia Rockberg and Aman Mebrahtu. Johan is Professor in Antibody engineering and Directed evolution at KTH. Julia and Aman both hold PhDs in molecular biotechnology from KTH.

About the KTH Innovation pre-incubator program

The KTH Innovation pre-incubator program is a 12-month program for promising startup projects from KTH. We welcome new teams into the program twice a year. Around 10% of all ideas that KTH Innovation supports go to the pre-incubator program.

In addition to business development support from KTH Innovation, the teams in the program get access to offices and meeting rooms in KTH Innovation's premises at Teknikringen 1. Every week, they meet over lunch and take part in a tailor-made workshop program.

They also get access to our makerspace and production studio. Together with the program's over 250 alumni projects, they form a supportive community, growing and developing together.

Participants in the program also get an opportunity to get an experienced mentor via KTH Innovation's mentor program, and to pitch for a SEK 250,000 in investment from KTH Holding AB.

Studies

Research

Collaboration

About KTH

Library

SLEdgehammer

Team & KTH connection